208 related articles for article (PubMed ID: 14576140)
1. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Rodero L; Mellado E; Rodriguez AC; Salve A; Guelfand L; Cahn P; Cuenca-Estrella M; Davel G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2003 Nov; 47(11):3653-6. PubMed ID: 14576140
[TBL] [Abstract][Full Text] [Related]
2. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
[TBL] [Abstract][Full Text] [Related]
3. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
Carvajal SK; Melendres J; Escandón P; Firacative C
Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Khyriem AB; Sujatha S; Parija SC
Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
[TBL] [Abstract][Full Text] [Related]
8. Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole.
Kano R; Okubo M; Hasegawa A; Kamata H
Med Mycol; 2017 Nov; 55(8):877-882. PubMed ID: 28927230
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
de Carvalho Santana R; Schiave LA; Dos Santos Quaglio AS; de Gaitani CM; Martinez R
Mycopathologia; 2017 Oct; 182(9-10):855-861. PubMed ID: 28656554
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
Venkateswarlu K; Taylor M; Manning NJ; Rinaldi MG; Kelly SL
Antimicrob Agents Chemother; 1997 Apr; 41(4):748-51. PubMed ID: 9087482
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformans.
Revankar SG; Fu J; Rinaldi MG; Kelly SL; Kelly DE; Lamb DC; Keller SM; Wickes BL
Biochem Biophys Res Commun; 2004 Nov; 324(2):719-28. PubMed ID: 15474487
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
[TBL] [Abstract][Full Text] [Related]
13. Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance.
Edlind TD; Henry KW; Metera KA; Katiyar SK
Med Mycol; 2001 Jun; 39(3):299-302. PubMed ID: 11446535
[TBL] [Abstract][Full Text] [Related]
14. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
Sanglard D; Ischer F; Koymans L; Bille J
Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole-resistant cryptococcal meningitis.
Momoff N; Parrish A
S Afr Med J; 2003 Jun; 93(6):444. PubMed ID: 12916384
[No Abstract] [Full Text] [Related]
16. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD
Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
[TBL] [Abstract][Full Text] [Related]
17. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
Favre B; Didmon M; Ryder NS
Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
[TBL] [Abstract][Full Text] [Related]
18. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.
Paugam A; Dupouy-Camet J; Blanche P; Gangneux JP; Tourte-Schaefer C; Sicard D
Clin Infect Dis; 1994 Nov; 19(5):975-6. PubMed ID: 7893896
[No Abstract] [Full Text] [Related]
19. Cloning of the lanosterol 14-α-demethylase ( ERG11 ) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in T. asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Shirai R; Kishi K; Hiramatsu K; Kadota J
FEMS Yeast Res; 2012 Sep; 12(6):662-7. PubMed ID: 22621704
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
Casadevall A; Spitzer ED; Webb D; Rinaldi MG
Antimicrob Agents Chemother; 1993 Jun; 37(6):1383-6. PubMed ID: 8328793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
